How does Biodexa Pharmaceuticals Plc (BDRX)'s PE ratio compare to its industry?

Biodexa Pharmaceuticals Plc (BDRX) trades at a PE of 0.0 versus a Biotechnology Industry median of 20.1 (695 companies). A relative PE gap is one signal, not investment advice — see the full DCF fair value at evidinvest.com/valuation/BDRX.

BDRX PE Benchmarks

Biodexa Pharmaceuticals Plc • Healthcare

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.

PE Type:

Period:

Data Quality:Good

Current PE Ratio

N/A

Diluted • annual

Forward PE

N/A

NTM Estimate

Sector Companies

500

307 with PE data

Sector Median PE

79.9

307 companies

Peer Companies

0

Direct competitors

Sector Analysis: Healthcare

Total Companies

500

With PE Data

307

Median PE

79.9

PE Range

3.1 - 198.9

Forward PE Median

21.1

Healthcare Sector

2901 companies • sector

Unknown

Current PE:N/A

Forward PE:N/A

Median PE:22.3

Average PE:35.7

Min PE:0.1

Max PE:198.8

25th-75th %ile:10.9 - 44.7

Biotechnology Industry

695 companies • industry

Unknown

Current PE:N/A

Forward PE:N/A

Median PE:20.1

Average PE:35.5

Min PE:0.1

Max PE:198.1

25th-75th %ile:6.7 - 47.3

GB Market

656 companies • country

Unknown

Current PE:N/A

Forward PE:N/A

Median PE:22.5

Average PE:46.6

Min PE:0.1

Max PE:198.8

25th-75th %ile:11.3 - 58.4

Stock List PE Comparison

No stock lists found. Create one in Stock Lists.

About PE Benchmarks

• Sector: Companies in the same broad industry sector
• Industry: Companies in the same specific industry classification
• Peers: Direct competitors identified through business analysis
• Position: Where this stock ranks relative to the benchmark group
• Forward PE: Based on next 4 quarters analyst EPS estimates from earnings data

Last updated: 8/28/2026, 11:20:15 AM• Based on latest annual diluted PE ratios

BDRX PE Benchmarks

Biodexa Pharmaceuticals Plc • Healthcare

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.

PE Type:

Period:

Data Quality:Good

Current PE Ratio

N/A

Diluted • annual

Forward PE

N/A

NTM Estimate

Sector Companies

500

307 with PE data

Sector Median PE

79.9

307 companies

Peer Companies

0

Direct competitors

Sector Analysis: Healthcare

Total Companies

500

With PE Data

307

Median PE

79.9

PE Range

3.1 - 198.9

Forward PE Median

21.1

Healthcare Sector

2901 companies • sector

Unknown

Current PE:N/A

Forward PE:N/A

Median PE:22.3

Average PE:35.7

Min PE:0.1

Max PE:198.8

25th-75th %ile:10.9 - 44.7

Biotechnology Industry

695 companies • industry

Unknown

Current PE:N/A

Forward PE:N/A

Median PE:20.1

Average PE:35.5

Min PE:0.1

Max PE:198.1

25th-75th %ile:6.7 - 47.3

GB Market

656 companies • country

Unknown

Current PE:N/A

Forward PE:N/A

Median PE:22.5

Average PE:46.6

Min PE:0.1

Max PE:198.8

25th-75th %ile:11.3 - 58.4

Stock List PE Comparison

No stock lists found. Create one in Stock Lists.

About PE Benchmarks

• Sector: Companies in the same broad industry sector
• Industry: Companies in the same specific industry classification
• Peers: Direct competitors identified through business analysis
• Position: Where this stock ranks relative to the benchmark group
• Forward PE: Based on next 4 quarters analyst EPS estimates from earnings data

Last updated: 8/28/2026, 11:20:15 AM• Based on latest annual diluted PE ratios

BDRX PE Benchmarks

Sector Analysis: Healthcare

Healthcare Sector

Biotechnology Industry

GB Market

Stock List PE Comparison

More on BDRX

Compare with peers

Explore

BDRX PE Benchmarks

Sector Analysis: Healthcare

Healthcare Sector

Biotechnology Industry

GB Market

Stock List PE Comparison

More on BDRX

Compare with peers

Explore